DOTATATE PET Imaging in Olfactory Neuroblastoma and Association with SSTR Expression

Daniel E Palmieri1, Kent S Tadokoro2, Benita Valappil2

  • 1University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States.

Insights

All olfactory neuroblastomas (ONBs) express somatostatin receptors (SSTRs), showing DOTATATE avidity. This suggests Ga-68 DOTATATE PET/CT is a valuable imaging tool for monitoring recurrent and metastatic olfactory neuroblastoma.

Area of Science:

  • Oncology
  • Nuclear Medicine
  • Radiology

Background:

  • Olfactory neuroblastoma (ONB) is a rare nasal cavity tumor.
  • Somatostatin receptors (SSTRs) are often expressed in ONB.
  • Ga-68 DOTATATE PET/CT is a potential imaging modality for ONB.

Purpose of the Study:

  • To evaluate the utility of Ga-68 DOTATATE PET/CT in patients with olfactory neuroblastoma.
  • To assess the correlation between SSTR2 expression and DOTATATE avidity in ONB.

Main Methods:

  • Retrospective review of 96 endoscopic endonasal skull base surgery cases for ONB.
  • Histo (H) scores and normalized DOTATATE standardized uptake values (nSUVs) were measured.
  • Nine ONB patients were included.

Main Results:

  • All included ONBs showed positive SSTR2 expression (mean H-score: 180).
  • All ONBs demonstrated DOTATATE avidity (mean nSUV: 6.7).
  • No significant correlation was found between H-score and nSUV (r² = 0.24, p = 0.18).

Conclusions:

  • SSTR2 expression is consistently present in ONB.
  • DOTATATE avidity is observed in all ONBs.
  • Ga-68 DOTATATE PET/CT may be a valuable imaging tool for monitoring recurrent and metastatic ONB.